Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-08-25FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for Oxybutynin Chloride submitted by Ajanta Pharma USA Inc.
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB [Phase 4]
Phase 4 trial comparing tadalafil/solifenacin vs tamsulosin/solifenacin for BPH with concomitant overactive bladder; current status unknown.
-
CLINICAL_TRIALS trial_result · 2022-07-11Clinical Trial Update: Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study [Phase 4]
Prospective multicenter randomized controlled Phase 4 trial evaluating mirabegron combined with behavioral intervention for overactive bladd…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Over Active Bladder Patients Having Sling Surgery [NA]
A terminated clinical trial evaluating sling surgery for overactive bladder with results posted.
-
FDA approval · 2022-06-15FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic solifenacin succinate under an original ANDA submission, marking the approval of a generic vers…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Clinical Feasibility Study, Implantable Tibial Nerve Stimulator (ITNS) [NA]
Clinical feasibility study for an implantable tibial nerve stimulator in overactive bladder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population [NA]
Clinical trial update on feasibility of parasacral transcutaneous electrical nerve stimulation (PTENS) for voiding dysfunction in pediatric …
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome [Phase 4]
A Phase 4 trial suggests tolterodine may relieve symptoms of overactive bladder in women with moderate-to-severe obstructive sleep apnea.
-
FDA approval · 2022-02-18FDA Approved: DARIFENACIN — Supplemental Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s supplemental application for darifenacin hydrobromide (DARIFENACIN). This action expands regulatory cleara…
-
FDA approval · 2022-02-16FDA Approved: TROSPIUM CHLORIDE — Original Application (Zameer Pharmaceuticals LLC)
FDA approved an original application for trospium chloride (generic) from Zameer Pharmaceuticals LLC, granting market authorization. It is i…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children [Phase 1, Phase 2]
Clinical trial update for beta 3 agonists exploring treatment of voiding disorders and overactive bladder in children, currently in Phase 1/…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: OnabotulinumtoxinA Bladder Injection Study [Phase 4]
Phase 4 trial of onabotulinumtoxinA injected into the bladder for overactive bladder has been terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder [Phase 3]
Phase 3 trial evaluating JLP-2002 for efficacy and safety in overactive bladder has completed.
-
FDA approval · 2022-01-26FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Novadoz Pharmaceuticals LLC)
The FDA approved a supplemental application for solifenacin succinate from Novadoz Pharmaceuticals LLC, authorizing changes to the product l…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial [Phase 4]
A multicenter, randomized, open-label, crossover Phase 4 trial evaluating sequencing and combination of mirabegron and TTNS for overactive b…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial [Phase 4]
Phase 4 randomized trial comparing number of injection sites for in-office intravesical onabotulinumtoxinA in overactive bladder.
-
FDA approval · 2021-12-03FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Solifenacin succinate from ScieGen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study [NA]
Completed post-market follow-up study for InterStim basic evaluation lead in patients with overactive bladder and urinary urge incontinence;…
-
FDA approval · 2021-10-18FDA Approved: OXYBUTYNIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA has approved a supplemental application for Oxybutynin from Zydus Pharmaceuticals USA Inc., indicating an updated approval for the p…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: BOTOX® at the Time of Prolapse Surgery for OAB [Phase 4]
Phase 4 clinical trial update evaluating Botox at the time of prolapse surgery for overactive bladder symptoms.
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Comparison of Motor and Sensory Response With Interstim Stimulation [NA]
Completed clinical trial comparing motor and sensory response with interstim stimulation for overactive bladder and urgency-frequency; resul…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Investigation of the Effect of the Female Urinary Microbiome on Incontinence [Phase 4]
Phase 4 trial investigating the effect of the female urinary microbiome on urinary incontinence outcomes has completed with results posted.
-
FDA approval · 2021-09-15FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for oxybutynin chloride from Strides Pharma Science Limited. Oxybutynin chloride is used to treat ov…
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO) [Phase 4]
Pilot Phase 4 trial evaluating mirabegron plus pelvic floor exercise for overactive bladder symptoms in Parkinson's disease; results posted …
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence [Phase 2]
Phase 2 clinical trial evaluating intravesical Botox (onabotulinumtoxinA) for overactive bladder with urinary incontinence has completed wit…